Search Results

First-in-Human Study Evaluates Anaconda Biomed's Next-Generation Stroke Thrombectomy System

November 5, 2019—Anaconda Biomed, a company developing a next-generation thrombectomy system for the treatment of ischemic stroke, announced the completion of initial patient cases in a first-in-human study at Hospital Vall d’Hebron in Barcelona, Spain.

Perflow Medical Announces Financing to Support Cerebral Aneurysm Technology; Progress With Stroke Platform

February 15, 2018—Perflow Medical has announced the closing of $12 million in financing aimed at supporting commercialization of its Stream Net device in Europe and other countries, as well as for submission of 510(k) review in the United States.

Enrollment Begins in MARRS Pivotal Trial of Perfuze Millipede System

November 7, 2023—Perfuze, an Ireland-based medical device company developing technology to treat acute ischemic stroke, recently announced commencement of enrollment in its pivotal MARRS clinical study.

Royal Philips’ Direct to Angio Suite to Improve Stroke Outcomes Evaluated in WE-TRUST Trial

July 7, 2021—Royal Philips announced the beginning of the WE-TRUST randomized controlled trial to assess if the company’s Direct to Angio Suite workflow can improve outcomes for early time-window stroke patients (< 6 hours after stroke onset).

Three Rivers Medical's Rio Embolization Coil System Receives CE Mark Approval

February 20, 2018-Three Rivers Medical, Inc. announced that it has received CE Mark approval for the Rio embolization coil system, which is indicated for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulas.

Cook Medical Gains CE Mark for PVA Foam Embolization Particles to Treat Benign Prostatic Hyperplasia

May 3, 2013—Cook Medical (Bloomington, IN) announced that it has received CE Mark approval for its PVA foam embolization particles for the treatment of symptomatic benign prostatic hyperplasia (BPH).